MrC's Smallcap Sweeps for Aug 2023
Posted: August 1st, 2023, 7:37 am
Smallcap Sweep. 01-Aug-23
It's all hands on tech
Ethernity Networks (ENET) update on its recent $1.5m order, strategy and trading. Has delivered c. 40% of the order in June and been paid. Strategy: co's customized PON solution on FPGAs will be offered on a licensing model. Guides FY23 rev miss but improved gross margin once licensing sales commence. [SP=1.8 Cap=2m]
Saietta (SED) suite of contracts will replace the Joint Commercialisation and Development Agreement with Consolidated Metco." This will enable Saietta to narrow its near-term focus on immediate revenue generating opportunities " SED gets €3.3m and will incur no further costs. This has already been factored into market guidance. [SP=45 Cap=46m]
Symphony Environmental Technologies (SYM) guides H1-June rev up 10% and gross margin over 42% (36%). In line? [SP=7.99 Cap=15m]
C4X Discovery (C4XD) sells Orexin-1 receptor antagonist, C4X_3256 for £16m. Forms part of C4XD's evolution towards becoming an immuno-inflammatory therapeutics co. [SP=20.2 Cap=51m]
Cellular Goods (CBX) Look Better (skincare) range will soon be available in France and Germany, online. [SP=0.75 Cap=5m]
Minoan (MIN) will collaborate with a major international luxury hotel group in relation to one or more of the hotels in Minoan's Itanos Gaia Project in Crete. [SP=0.96 Cap=7m]
Ondine Biomedical (OBI) starts first NHS Steriwave (non-antibiotic method of preventing infections after surgery) pilot. [SP=15.34 Cap=30m]
Journeo (JNEO) guides FY-Dec rev £41m, significantly ahead of market expectations, with profit marginally ahead. H1 rev up 145% to £21.8m. "Sales of lower margin products were higher than expected in H1 2023 and this is expected to continue throughout most of H2." [SP=181 Cap=29m]
Belluscura (BELL) gets US distributor for X-PLOR portable oxygen concentrator. [SP=32 Cap=43m]
Plant Health Care (PHC) Harpin αβ, a fertiliser with biostimulant properties, approved in Poland. [SP=9.1 Cap=31m]
Barkby (BARK) completes disposal of Workshop Trading for £0.3m deferred. Gets transfer of £1.7m of third-party liabilities and repayment of £0.2m loan. [SP=3 Cap=5m]
In line: EXR, RCDO
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
It's all hands on tech
Ethernity Networks (ENET) update on its recent $1.5m order, strategy and trading. Has delivered c. 40% of the order in June and been paid. Strategy: co's customized PON solution on FPGAs will be offered on a licensing model. Guides FY23 rev miss but improved gross margin once licensing sales commence. [SP=1.8 Cap=2m]
Saietta (SED) suite of contracts will replace the Joint Commercialisation and Development Agreement with Consolidated Metco." This will enable Saietta to narrow its near-term focus on immediate revenue generating opportunities " SED gets €3.3m and will incur no further costs. This has already been factored into market guidance. [SP=45 Cap=46m]
Symphony Environmental Technologies (SYM) guides H1-June rev up 10% and gross margin over 42% (36%). In line? [SP=7.99 Cap=15m]
C4X Discovery (C4XD) sells Orexin-1 receptor antagonist, C4X_3256 for £16m. Forms part of C4XD's evolution towards becoming an immuno-inflammatory therapeutics co. [SP=20.2 Cap=51m]
Cellular Goods (CBX) Look Better (skincare) range will soon be available in France and Germany, online. [SP=0.75 Cap=5m]
Minoan (MIN) will collaborate with a major international luxury hotel group in relation to one or more of the hotels in Minoan's Itanos Gaia Project in Crete. [SP=0.96 Cap=7m]
Ondine Biomedical (OBI) starts first NHS Steriwave (non-antibiotic method of preventing infections after surgery) pilot. [SP=15.34 Cap=30m]
Journeo (JNEO) guides FY-Dec rev £41m, significantly ahead of market expectations, with profit marginally ahead. H1 rev up 145% to £21.8m. "Sales of lower margin products were higher than expected in H1 2023 and this is expected to continue throughout most of H2." [SP=181 Cap=29m]
Belluscura (BELL) gets US distributor for X-PLOR portable oxygen concentrator. [SP=32 Cap=43m]
Plant Health Care (PHC) Harpin αβ, a fertiliser with biostimulant properties, approved in Poland. [SP=9.1 Cap=31m]
Barkby (BARK) completes disposal of Workshop Trading for £0.3m deferred. Gets transfer of £1.7m of third-party liabilities and repayment of £0.2m loan. [SP=3 Cap=5m]
In line: EXR, RCDO
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian